Cardiovascular disease screening in general practice: general practitioner recording of common risk factors
The assessment and screening of individual risk factors for cardiovascular disease (CVD) is
a critical component of CVD prevention strategies in general practice (GP). This study …
a critical component of CVD prevention strategies in general practice (GP). This study …
The effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled RxEACH trial
Background: Despite the cardiovascular disease (CVD) risk associated with hypertension,
diabetes, dyslipidemia, and smoking, these risk factors remain poorly identified and …
diabetes, dyslipidemia, and smoking, these risk factors remain poorly identified and …
Comparison of Screening Guidelines for Cardiovascular disease Prevention and Early Detection: a scoping review
Objective: Globally, cardiovascular disease (CVD) has a significant role in morbidity and
early death. This review's objective is to provide a summary of the strengths and …
early death. This review's objective is to provide a summary of the strengths and …
Evaluation of a community pharmacy–based screening questionnaire to identify patients at risk for drug therapy problems
RT Pammett, D Blackburn, J Taylor… - … : The Journal of …, 2015 - Wiley Online Library
Study Objective To determine if a short screening questionnaire can identify patients at risk
for drug therapy problems (DTP s) in a community pharmacy setting. Design Self …
for drug therapy problems (DTP s) in a community pharmacy setting. Design Self …
Missed opportunities in prevention of cardiovascular disease in primary care: a cross-sectional study
JP Sheppard, K Fletcher, RJ McManus… - British Journal of General …, 2014 - bjgp.org
Background Screening cardiovascular disease (CVD) risk is an important part of CVD
prevention. The success of screening is dependent on the rigour with which treatments are …
prevention. The success of screening is dependent on the rigour with which treatments are …
Design and implementation of surveys to assess patient and healthcare provider understanding of risks and safe use conditions
K Hollis, A Gilsenan - Mann's Pharmacovigilance, 2014 - Wiley Online Library
Both the US Food and Drug Administration and European Medicines Agency require
assessments of the effectiveness of risk evaluation and mitigation strategies and risk …
assessments of the effectiveness of risk evaluation and mitigation strategies and risk …
The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting
Risk factors for cardiovascular disease including diabetes have seen a large rise in
prevalence in recent years. This has prompted interest in prevention through the identifying …
prevalence in recent years. This has prompted interest in prevention through the identifying …
Cardiovascular risk assessment: a systematic review of guidelines
MY Khanji, VVS Bicalho… - Annals of internal …, 2016 - acpjournals.org
Background: Many guidelines exist for screening and risk assessment for the primary
prevention of cardiovascular disease in apparently healthy persons. Purpose: To …
prevention of cardiovascular disease in apparently healthy persons. Purpose: To …
Multidisciplinary vascular screening program modestly improves the medical treatment of vascular risk factors
BMB Goessens, FLJ Visseren, JK Olijhoek… - … drugs and therapy, 2005 - Springer
Purpose: This study investigated whether recommendations given to the treating vascular
specialist and the GP by a multidisciplinary team of vascular specialists concerning the …
specialist and the GP by a multidisciplinary team of vascular specialists concerning the …
The MyHealthCheckup study: Training graduate students to implement cardiovascular risk screening programs in community pharmacies
Background: Hypertension is a major risk factor for cardiovascular morbidity and mortality.
Despite this fact and the development of efective antihypertensive drug therapy …
Despite this fact and the development of efective antihypertensive drug therapy …